Philippe Sultanik

716 total citations
40 papers, 284 citations indexed

About

Philippe Sultanik is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Philippe Sultanik has authored 40 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 24 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Philippe Sultanik's work include Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (22 papers) and Organ Transplantation Techniques and Outcomes (9 papers). Philippe Sultanik is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (22 papers) and Organ Transplantation Techniques and Outcomes (9 papers). Philippe Sultanik collaborates with scholars based in France, United States and Italy. Philippe Sultanik's co-authors include Dominique Thabut, Marika Rudler, Stanislas Pol, Maxime Mallet, Vincent Mallet, Estelle Mottez, Armanda Casrouge, Kristin V. Tarbell, Jeffrey D. Price and Jérémie Decalf and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Philippe Sultanik

36 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Sultanik France 10 163 149 64 52 29 40 284
Seung Kak Shin South Korea 11 156 1.0× 170 1.1× 60 0.9× 39 0.8× 30 1.0× 34 289
Barbara Lei Italy 8 143 0.9× 153 1.0× 35 0.5× 30 0.6× 49 1.7× 9 257
Jessica P.E. Davis United States 10 157 1.0× 143 1.0× 73 1.1× 31 0.6× 30 1.0× 28 273
Masaya Tamano Japan 10 150 0.9× 141 0.9× 98 1.5× 51 1.0× 22 0.8× 66 333
Emilia Prakoso Australia 11 145 0.9× 179 1.2× 94 1.5× 72 1.4× 35 1.2× 18 326
Nehad Hawash Egypt 10 224 1.4× 237 1.6× 59 0.9× 31 0.6× 60 2.1× 27 357
Isabelle D Munsterman Netherlands 8 103 0.6× 218 1.5× 98 1.5× 42 0.8× 27 0.9× 10 285
Rooshi Nathwani United Kingdom 8 187 1.1× 210 1.4× 74 1.2× 53 1.0× 15 0.5× 14 324
Kazuyuki Mizuno Japan 11 215 1.3× 221 1.5× 34 0.5× 72 1.4× 73 2.5× 41 381
Ferial El-Kalla Egypt 13 245 1.5× 225 1.5× 160 2.5× 48 0.9× 31 1.1× 29 418

Countries citing papers authored by Philippe Sultanik

Since Specialization
Citations

This map shows the geographic impact of Philippe Sultanik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Sultanik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Sultanik more than expected).

Fields of papers citing papers by Philippe Sultanik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Sultanik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Sultanik. The network helps show where Philippe Sultanik may publish in the future.

Co-authorship network of co-authors of Philippe Sultanik

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Sultanik. A scholar is included among the top collaborators of Philippe Sultanik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Sultanik. Philippe Sultanik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sultanik, Philippe, Charles Roux, Nicolas Weiss, et al.. (2025). Overt hepatic encephalopathy after elective and preemptive TIPS: Risk factors and prognosis. JHEP Reports. 7(11). 101548–101548. 1 indexed citations
2.
Rudler, Marika, et al.. (2025). Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit. United European Gastroenterology Journal. 13(5). 738–749. 1 indexed citations
3.
Sultanik, Philippe, et al.. (2024). Prevalence and prognosis of patients with MASLD ‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study. Alimentary Pharmacology & Therapeutics. 60(6). 796–810. 4 indexed citations
4.
Allaire, Manon, Philippe Sultanik, & Dominique Thabut. (2024). Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC. JHEP Reports. 6(8). 101120–101120. 2 indexed citations
5.
Sultanik, Philippe, Damien Galanaud, Vincent Navarro, et al.. (2024). Other causes of neurocognitive impairment than covert hepatic encephalopathy ( CHE ) are very frequent, either alone or associated with CHE , in cirrhotic patients with cognitive complaints. Alimentary Pharmacology & Therapeutics. 60(6). 749–764. 2 indexed citations
6.
Sultanik, Philippe, Claudia Campani, Charles Roux, et al.. (2024). Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab. Digestive and Liver Disease. 56(9). 1621–1630. 7 indexed citations
7.
Gairing, Simon Johannes, Lisa Zarantonello, Philippe Sultanik, et al.. (2024). PHES scores have limited impact on the risk of overt HE in patients with minimal HE. Hepatology Communications. 8(5).
8.
Gairing, Simon Johannes, Lisa Zarantonello, Philippe Sultanik, et al.. (2024). Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study. JHEP Reports. 6(8). 101104–101104. 3 indexed citations
9.
Gairing, Simon Johannes, Lisa Zarantonello, Stefania Gioia, et al.. (2023). Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival. Journal of Internal Medicine. 295(3). 331–345. 13 indexed citations
10.
Campani, Claudia, Manon Allaire, Philippe Sultanik, et al.. (2023). Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab. Hepatology. 79(1). 49–60. 14 indexed citations
11.
Weiss, Nicolas, Simona Tripon, Maxime Mallet, et al.. (2023). Protein-S-100-beta is increased in patients with decompensated cirrhosis admitted to ICU. SHILAP Revista de lepidopterología. 4(2). 222–230. 2 indexed citations
12.
Couty, Jean‐Pierre, Philippe Sultanik, Claudia Campani, et al.. (2023). Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC. Clinics and Research in Hepatology and Gastroenterology. 47(8). 102199–102199. 1 indexed citations
13.
Thabut, Dominique, et al.. (2023). Population characteristics, healthcare pathways and outcomes of patients with cirrhosis hospitalized with overt hepatic encephalopathy in France: A study of the French Hospital‐Discharge Database. Clinics and Research in Hepatology and Gastroenterology. 48(3). 102274–102274. 1 indexed citations
14.
Sultanik, Philippe, Lorraine Blaise, Mathilde Wagner, et al.. (2022). A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC. Liver International. 42(12). 2843–2854. 19 indexed citations
15.
Rudler, Marika, et al.. (2020). Optimal management of ascites. Liver International. 40(S1). 128–135. 21 indexed citations
16.
Sultanik, Philippe, et al.. (2017). Frontal sinus revision rate after nasal polyposis surgery including frontal recess clearance and middle turbinectomy: A long-term analysis. Auris Nasus Larynx. 45(4). 740–746. 5 indexed citations
17.
Decalf, Jérémie, Kristin V. Tarbell, Armanda Casrouge, et al.. (2016). Inhibition of DPP 4 activity in humans establishes its in vivo role in CXCL 10 post‐translational modification: prospective placebo‐controlled clinical studies. EMBO Molecular Medicine. 8(6). 679–683. 41 indexed citations
18.
Sultanik, Philippe, Vincent Mallet, Sylvie Lagaye, et al.. (2015). Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors‐based therapy. Liver International. 35(7). 1833–1844. 5 indexed citations
19.
Sultanik, Philippe, Armanda Casrouge, Estelle Mottez, et al.. (2013). 1177 BASELINE Phospho-Stat1 LEVEL IN PBMC IS A NON-INVASIVE BIOMARKER OF EARLY VIROLOGICAL RESPONSE TO TRIPLE THERAPY IN CHRONIC HCV INFECTION – ANRS C10–08 STUDY. Journal of Hepatology. 58. S478–S478.
20.
Terrier, Benjamin, Fádi Fakhouri, Philippe Sultanik, Richard Delarue, & Aurélie Hummel. (2006). La fuite urinaire d'érythropoïétine : une cause méconnue d'anémie au cours des syndromes néphrotiques. La Revue de Médecine Interne. 27(8). 643–645. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seung Kak Shin Breakdown of academic impact, for papers by Barbara Lei Breakdown of academic impact, for papers by Jessica P.E. Davis Breakdown of academic impact, for papers by Masaya Tamano Breakdown of academic impact, for papers by Emilia Prakoso Breakdown of academic impact, for papers by Nehad Hawash Breakdown of academic impact, for papers by Isabelle D Munsterman Breakdown of academic impact, for papers by Rooshi Nathwani Breakdown of academic impact, for papers by Kazuyuki Mizuno Breakdown of academic impact, for papers by Ferial El-Kalla
Rankless by CCL
2026